UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000025789
Receipt No. R000029660
Official scientific title of the study Sinus Floor Elevation Using Terufill Bone Substitute.
Date of disclosure of the study information 2017/02/01
Last modified on 2019/03/07 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Sinus Floor Elevation Using Terufill Bone Substitute.
Title of the study (Brief title) Sinus Floor Elevation Using Terufill Bone Substitute.
Region
Japan

Condition
Condition Severe Alveolar Bone Resorption
Classification by specialty
Dental medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Success of Implant Treatment
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Implant Osseointegration (six months after surgery)
Key secondary outcomes Adverse Event

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Applying Terufill for Sinus Floor Elevation
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
75 years-old >=
Gender Male and Female
Key inclusion criteria From 18 to 75 years-old patients having severe alveolar bone resorption who are adaptable for implant treatment.
Key exclusion criteria 1) immune deficiency
2) uncontrolled diabetes
3) under 17 years-old or over 76 years-old
Target sample size 10

Research contact person
Name of lead principal investigator Kawana Hiromasa
Organization Keio University School of Medicine
Division name Division of Dentistry and Oral Surgery
Address 35 Shinanomachi, Shinjuku-ku, Tokyo
TEL 03-5363-3831
Email kawana@keio.jp

Public contact
Name of contact person Miyashita Hidetaka
Organization Keio University School of Medicine
Division name Division of Dentistry and Oral Surgery
Address 35 Shinanomachi, Shinjuku-ku, Tokyo
TEL 03-5363-3831
Homepage URL
Email miyashita@keio.jp

Sponsor
Institute Keio University
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 02 Month 01 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2016 Year 11 Month 14 Day
Anticipated trial start date
2017 Year 02 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 01 Month 21 Day
Last modified on
2019 Year 03 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029660